Literature DB >> 11233722

Cutaneous alternariosis in a cardiac transplant recipient.

T K Gilmour1, E Rytina, P B O'Connell, J C Sterling.   

Abstract

A 55-year-old male cardiac transplant recipient presented with cutaneous nodules on the limbs caused by Alternaria alternata. Oral fluconazole 200 mg daily for 3 weeks was ineffective. Itraconazole 100 mg oral daily was ceased when hyperglycaemia developed. Individual lesions were successfully treated with either curettage and cautery or double freeze-thaw cryotherapy. Alternaria spp. are ubiquitous fungal saprophytes which may cause cutaneous infections particularly in immunocompromised patients.

Entities:  

Mesh:

Year:  2001        PMID: 11233722     DOI: 10.1046/j.1440-0960.2001.00473.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  5 in total

1.  Relapsing cutaneous alternariosis in a kidney transplant recipient cured with liposomal amphotericin B.

Authors:  E Merino; J Bañuls; V Boix; A Franco; J Guijarro; J Portilla; I Betlloch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-16       Impact factor: 3.267

Review 2.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Utility of molecular identification in opportunistic mycotic infections: a case of cutaneous Alternaria infectoria infection in a cardiac transplant recipient.

Authors:  G Lo Cascio; M Ligozzi; L Maccacaro; R Fontana
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 4.  Isolation of Alternaria alternata from an emollient cream: implications for public health.

Authors:  B Cherie Millar; J Xu; M James Walker; Noeleen A M Boyd; Ronan McMullan; John E Moore
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

5.  [Cutaneous alternariosis. Clinical diagnosis and therapeutic options].

Authors:  P Mayser; W Thoma; M Seibold; K Tintelnot; K Wiedemeyer; G S de Hoog
Journal:  Hautarzt       Date:  2004-12       Impact factor: 0.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.